Clinical Trial Update: Place of Copeptin-troponin Assay in the Elimination Diagnosis of Non-ST+ ACS [NA]

View source ↗

Summary

The clinical trial NCT05902117 evaluating a copeptin-troponin biomarker assay for ruling out non-ST-elevation acute coronary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Non-st-elevation Acute Coronary Syndrome

Snippet

Sponsor: Hôpital NOVO | Conditions: Acute Myocardial Infarction | NA | Status: COMPLETED